Sutro Biopharma, Inc. (STRO) income statement
STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$8.50−0.42 (-4.71%)
Close on Nov 18, 2026Market cap $140.94MP/E –Yield –
Sutro Biopharma, Inc. financial ratios
See a number that looks wrong?